TLDR: Firefly Bio has emerged from stealth mode with $94 million in funding co-led by Versant Ventures and MPM BioImpact. The company has assembled an “ADC dream team” to work on developing degrader-antibody conjugates (DACs), a new class of therapies to fight cancer. The team, led by CEO Scott Hirsch, includes scientists with backgrounds at Genentech, Merck & Co., and AbbVie, as well as Nobel laureate Carolyn Bertozzi. Firefly’s platform focuses on protein degraders, which use the cell’s natural degradation machinery to eliminate disease-causing proteins. The company aims to deliver a more selective payload that can improve the therapeutic index and clinical outcomes for patients.
Igniting Potential: $94M Funds Firefly Bio’s Protein Breakthrough with ADC Dream Team
Latest from Blog
Venture Capital Boom: AI Startups Revolutionizing Healthcare Funding
TLDR: Healthcare AI startups have raised about $60 billion in venture capital funding over the past decade. Only over 5% of companies selling to health systems have matured beyond seed and early-stage
Decrease in Private Market Funding in Second Quarter
TLDR: Bloomberg article addresses the issue of unusual activity detection in computer networks. Readers are prompted to confirm they are not robots by clicking a box. Bloomberg recently published an article discussing
Impact Founder’s $250M Raise: VC Insight and Outlook
TLDR: Key Points: Bloomberg article addressing unusual activity detection on computer networks prompting users to verify they are not robots. Inquiries related to the message can be directed to the support team
Top 10 Biotech and AI Funding Rounds of the Week
TLDR: Big week for biotech and AI funding rounds Top 10 funding rounds highlighted The past week saw significant funding rounds in the biotech and AI sectors, with two notable nine-figure rounds
AI Startup World Labs Secures $230M Funding from Top Investors
TLDR: – AI startup World Labs launched with over $230 million in total funding led by Andreessen Horowitz, NEA, and Radical Ventures. – Co-founded by Fei-Fei Li, World Labs aims to enhance